Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe webpage has been updated to include new information about a study on Refractory Soft Tissue Sarcomas, including a new version revision and a specific study identifier. Additionally, some background information and eligibility criteria for the study have been removed.SummaryDifference53%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check51 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check72 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.